An analysis of factors that predict patient consent to take part in a randomized controlled trial

Family Practice

Volumn 24, Issue 4, 2007, Pages 388-394

  Fletcher, Kate ^a   Mant, Jonathan ^a   Holder, Roger ^a   Fitzmaurice, David ^a   Lip, Gregory Y H ^a   Hobbs, F D Richard ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Consent; Primary care; RCT; Recruitment

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL COMPETENCE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; HEART ATRIUM FIBRILLATION; HUMAN; INFORMED CONSENT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PATIENT CARE; PATIENT PARTICIPATION; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; REFUSAL TO PARTICIPATE;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DECISION MAKING; ENGLAND; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PATIENT PARTICIPATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WALES;

EID: 34548613112     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmm019     Document Type: Article

References (26)

1. Altman DG. Better reporting of randomised controlled trials: The CONSORT statement. Br Med J 1996; 313: 570-571.
2. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in randomised controlled trials: A systematic review. J Clin Epidemiol 1999; 52: 1143-1156.
3. Prescott RJ, Counsell CE, Gillespire WJ et al. Factors that limit the quality, number and progress of randomised controlled trials. Health Technol Assess 1999; 3: 1-143.
4. Gates S, Brocklehurst P, Campbell M, Elbourne D. Recruitment to multicentre trials. Br J Obstet Gynaecol 2004; 111: 3-5.
5. Foy R, Parry J, Duggan A et al. How evidence based are recruitment strategies to randomised controlled trials in primary care? Experience from seven studies. Fam Pract 2003; 20: 83-92.
6. Lovato L, Kristin M, Hertert S et al. Recruitment for controlled clinical trials: Literature summary and annotated bibliography. Control Clin Trials 1997; 18: 328-357.
7. Robinson EJ, Kerr CEP, Stevens AJ et al. Lay public's understanding of equipoise and randomisation in randomised controlled trials. Health Technol Assess 2005; 9: 1-192.
8. Mant JWF, Richards SH, Hobbs FD et al. Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): A randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]. BMC Cardiovasc Disord 2003; 3: 9.
9. Featherstone K, Donovan J. Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial. Br Med J 1998; 317: 1177-1180.
10. Schaeffer M, Krantz D, Wichman A, Masur H, Reed E, Vinicky J. The impact of disease severity on the informed consent process in clinical research. Am J Med; 100: 261-268.
11. Mills N, Donovan J, Smith M, Jacoby A, Neal D, Hamdy F. Perceptions of equipoise are crucial to trial participation: A qualitative study of men in the ProtecT study. Control Clin Trials 2003; 24: 272-282.
12. Fuller R, Dudley N, Blacktop J. Avoidance hierarchies and preferences for anticoagulation - semi-qualitative analysis of older patients'views about stroke prevention and the use of warfarin. Age Ageing 2004; 33: 608-611.
13. Jack WJ, Chetty U, Rodger A. Recruitment to a prospective breast conservation trial: Why are so few patients randomised? Br Med J 1990; 301: 83-85.
14. Petty DR, Zermansky AG, Raynor DK et al. 'No thank you': Why elderly patients declined to participate in a research study. Pharm World Sci 2001; 23: 22-27.
15. Mason SA, Allmark PJ. Obtaining informed consent to neonatal randomised controlled trials: Interviews with parents and clinicians in the Euricon study. Lancet 2000; 356: 2045-2051.
16. Van Walraven C, Hart RG, Singer DE et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis. J Am Med Assoc 2002; 288: 2441-2448.
17. Hetzel MR, Lee T, Prescott RJ et al. Multi-centre clinical respiratory research: A new approach. J R Coll Physicians Lond 1998; 32: 412-416.
18. Haidich A, Ioannidis J. Late-starter sites in randomised controlled trials. J Clin Epidemiol 2003; 56: 408-415.
19. Garcia D, Regan S, Crowther M, Hughes R, Hylek E. Warfarin maintenance dosing patterns in clinical practice: Implications for safer anticoagulation in the elderly population. Chest 2005; 127: 2049-2056.
20. Jenkins VA, Fallowfield LJ, Souhami A, Satwell M. How do doctors explain randomised clinical trials to their patients? Eur J Cancer 1999; 35: 1187-1193.
21. Verheggen FW, Jonkers R, Kok G. Patients' perceptions on informed consent and the quality of information disclosure in clinical trials. Patient Educ Couns 1996; 29: 137-153.
22. Von Bultzingslowen I, Eliasson G, Sarvimaki A, Mattsson B, Hjortdahl P. Patients' views on interpersonal continuity in primary care: A sense of security based on four core foundations. Fam Pract 2006; 23: 210-219.
23. Kearley K, Freeman G, Heath A. An exploration of the value of the personal doctor-patient relationship in general practice. Br J Gen Pract 2001; 712-718.
24. Hjortdahl P. Continuity of care: General practitioners' knowledge about and sense of responsibility toward their patients. Fam Pract 1992; 9: 3-8.
25. Mckinstry B, Yang S. Do patients care about the age of their general practitioner? A questionnaire survey in five practices. Br J Gen Pract 1994; 44: 349-351.
26. Donovan J, Mills N, Smith M et al. Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Br Med J 2002; 325: 766-770.